12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·08/06/2026 17:06:06
Listen to the news
Gainers
- Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday's regular session. The company's market cap stands at $4.3 million.
- Ensysce Biosciences (NASDAQ:ENSC) stock rose 47.81% to $0.54. The company's market cap stands at $5.5 million.
- Iovance Biotherapeutics (NASDAQ:IOVA) shares moved upwards by 37.44% to $5.96. The market value of their outstanding shares is at $1.9 billion. The company's, Q2 earnings came out today.
- Myomo (AMEX:MYO) stock increased by 32.07% to $1.4. The company's market cap stands at $40.9 million. As per the news, the Q2 earnings report came out yesterday.
- Insmed (NASDAQ:INSM) shares increased by 32.05% to $130.76. The company's market cap stands at $21.4 billion. As per the press release, Q2 earnings came out today.
- Sight Sciences (NASDAQ:SGHT) stock moved upwards by 27.74% to $7.09. The company's market cap stands at $301.9 million. As per the press release, Q2 earnings came out yesterday.
Losers
- BioVie (NASDAQ:BIVI) stock decreased by 51.0% to $1.0 during Thursday's regular session. The company's market cap stands at $15.3 million.
- BillionToOne (NASDAQ:BLLN) shares decreased by 38.39% to $92.4. The market value of their outstanding shares is at $6.8 billion. As per the news, the Q3 earnings report came out yesterday.
- Biote (NASDAQ:BTMD) stock fell 30.09% to $1.58. The market value of their outstanding shares is at $68.5 million. As per the press release, Q2 earnings came out yesterday.
- Emergent BioSolutions (NYSE:EBS) shares declined by 29.78% to $5.29. The company's market cap stands at $390.5 million. As per the news, the Q2 earnings report came out yesterday.
- Akebia Therapeutics (NASDAQ:AKBA) stock declined by 28.69% to $0.92. The company's market cap stands at $346.0 million. The company's, Q2 earnings came out yesterday.
- Context Therapeutics (NASDAQ:CNTX) shares declined by 25.47% to $0.52. The market value of their outstanding shares is at $63.6 million. The company's, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.